The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,166.00
Bid: 1,154.00
Ask: 1,158.00
Change: 8.00 (0.69%)
Spread: 4.00 (0.347%)
Open: 1,140.00
High: 1,168.00
Low: 1,140.00
Prev. Close: 1,158.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change in management at Georgia Healthcare Group

29 Jul 2022 15:06

RNS Number : 3143U
Georgia Capital PLC
29 July 2022
 

London, 29 July 2022

 

 

Georgia Capital announces that Nick Gamkrelidze is to step down as CEO of Georgia Healthcare

Georgia Capital PLC (the "Company" or "Georgia Capital") announces today that Nikoloz (Nick) Gamkrelidze is to step down as Chief Executive of JSC Georgia Healthcare Group ("GHG"), the wholly-owned subsidiary of Georgia Capital. He will be replaced as GHG's CEO by Irakli Gogia, currently Deputy CEO, Finance of GHG with immediate effect.

 

On 9 May 2022, the Board announced the separation of the roles of Georgia Capital's Chairman and CEO, upon the completion of Irakli Gilauri's current employment contract as Chairman and CEO in May 2023, with Irakli Gilauri continuing in the role of Board Chairman and Nick Gamkrelidze assuming the role of Chief Executive Officer in May 2023. Following Nick's departure from GHG, he will not now take up the role of Georgia Capital CEO in May 2023, and the Board of Georgia Capital will announce a further update in due course with regard to the appointment of a new CEO. Irakli Gilauri, as previously announced, will continue in his existing combined Chairman and CEO role until May 2023.

 

Irakli Gilauri, Chairman and CEO of Georgia Capital, commented: "Nick has been with the Group in a number of senior management positions for many years and has more recently been instrumental in the development of Georgia Healthcare over the last decade. He has created a great business that has delivered, and continues to do so, an excellent operational performance resulting in consistent strong growth and profitability. He has also been actively involved in Georgia's management of the global pandemic over the last 2 years, and he leaves with our strong gratitude for all of his outstanding achievements. Nick has also built and developed a fantastic management team, and it is great that we have Irakli Gogia in the position to succeed Nick with immediate effect."

 

Nick Gamkrelidze commented: "It has been my privilege to have led Georgia Healthcare through all of its successes over the last 7 years. The business is a great ongoing success story reflecting the significant progress the excellent management and clinical teams have made in institutionalising exceptional governance and high standards of clinical and operational performance. Going forward, the business could not be in better hands than those of Irakli Gogia, and I wish him and the entire team the very best success. I am certain they will continue to deliver exceptional performance."

 

Irakli Gogia commented: "It is a great honour and a privilege to take on the role of CEO of Georgia Healthcare Group. I would like to thank Nick for his invaluable contribution building the GHG healthcare institution, with a highly professional and capable management team, that creates substantial value for the country and for our shareholders."

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Michael Oliver, Adviser to the Chairman & CEO.

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of the UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a healthcare services business; (ii) a retail (pharmacy) business, (iii) an insurance business (P&C and medical insurance); (iv) a renewable energy business (hydro and wind assets) and (v) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20% equity stake in the water utility business and a 19.9% equity stake in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGZNDLKGZZM
Date   Source Headline
1st May 20247:00 amRNS1st Quarter Results
24th Apr 202412:30 pmRNSNotice of Results
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 202410:52 amRNSChange of Registered Office
3rd Apr 20245:29 pmRNSDirector/PDMR Shareholding
25th Mar 20245:29 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSAnnual Financial Report
14th Mar 20245:13 pmRNSDirector/PDMR Shareholding
29th Feb 202410:13 amRNSCancellation of Treasury Shares
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
23rd Feb 20243:58 pmEQSEdison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms
23rd Feb 20241:13 pmRNSTransaction in Own Shares
22nd Feb 20245:23 pmRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSFinal Results
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:18 pmRNSTransaction in Own Shares
19th Feb 20242:19 pmRNSTransaction in Own Shares
16th Feb 20244:29 pmRNSTransaction in Own Shares
15th Feb 20244:24 pmRNSTransaction in Own Shares
15th Feb 20243:15 pmRNSNotice of Results
14th Feb 20245:05 pmRNSTransaction in Own Shares
13th Feb 20243:19 pmRNSTransaction in Own Shares
9th Feb 20245:12 pmRNSTransaction in Own Shares
8th Feb 20245:17 pmRNSTransaction in Own Shares
7th Feb 20244:45 pmRNSTransaction in Own Shares
6th Feb 20243:23 pmRNSTransaction in Own Shares
5th Feb 20244:48 pmRNSTransaction in Own Shares
2nd Feb 20241:40 pmRNSTransaction in Own Shares
1st Feb 20244:57 pmRNSTransaction in Own Shares
1st Feb 202411:49 amRNSTotal Voting Rights
31st Jan 20245:03 pmRNSCancellation of Treasury Shares
31st Jan 20244:48 pmRNSTransaction in Own Shares
30th Jan 20243:26 pmRNSTransaction in Own Shares
29th Jan 20242:28 pmRNSTransaction in Own Shares
26th Jan 20245:32 pmRNSTransaction in Own Shares
25th Jan 20244:27 pmRNSTransaction in Own Shares
24th Jan 20243:25 pmRNSTransaction in Own Shares
23rd Jan 20241:58 pmRNSHolding(s) in Company
23rd Jan 202412:09 pmRNSTransaction in Own Shares
22nd Jan 20245:26 pmRNSTransaction in Own Shares
19th Jan 20243:55 pmRNSTransaction in Own Shares
19th Jan 20242:45 pmRNSDirector/PDMR Shareholding
18th Jan 20244:00 pmRNSTransaction in Own Shares
17th Jan 20245:20 pmRNSTransaction in Own Shares
16th Jan 20244:19 pmRNSTransaction in Own Shares
15th Jan 20245:14 pmRNSTransaction in Own Shares
12th Jan 20243:05 pmRNSTransaction in Own Shares
11th Jan 20243:54 pmRNSTransaction in Own Shares
10th Jan 20244:19 pmRNSTransaction in Own Shares
9th Jan 20245:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.